Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eng Huat Tan

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 6, 2022
Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trialRoss A Soo, Eng Huat Tan, Hidetoshi Hayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small-cell lung cancerSwan Swan Leong, Eng Huat Tan, Kam Weng Fong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2011
A Phase II study of pazopanib in Asian patients with recurrent/metastatic nasopharyngeal carcinomaWan-Teck Lim, Quan-Sing Ng, Percy Ivy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2011
Genomic profiles specific to patient ethnicity in lung adenocarcinomaPhilippe Broët, Cyril Dalmasso, Eng Huat Tan, et al.
Cancer|February 3, 2015
Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysisN Gopalakrishna Iyer, Daniel S W Tan, Veronique K M Tan, et al.
Cancer Immunology, Immunotherapy : CII|December 2, 2008
Phenotypic and functional alterations of Vgamma2Vdelta2 T cell subsets in patients with active nasopharyngeal carcinomaKia Joo Puan, John Seng Hooi Low, Terence Wee Kiat Tan, et al.
Head & Neck|June 24, 2014
Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinomaSiok-Hoon Ang, Benjamin Haaland, Sanchalika Acharyya, et al.
Head & Neck|February 6, 2021
Phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinomaMei-Kim Ang, Jose Enrique Montoya, Ekkasit Tharavichitkul, et al.
Clinical Pharmacology in Drug Development|January 19, 2018
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCEng-Huat Tan, Wan-Teck Lim, Myung-Ju Ahn, et al.
International Journal of Cancer|February 1, 2014
Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomicsDaniel S W Tan, Sophie Camilleri-Broët, Eng Huat Tan, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Lung Cancer (Amsterdam, Netherlands)|June 6, 2022
Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trialRoss A Soo, Eng Huat Tan, Hidetoshi Hayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small-cell lung cancerSwan Swan Leong, Eng Huat Tan, Kam Weng Fong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2011
A Phase II study of pazopanib in Asian patients with recurrent/metastatic nasopharyngeal carcinomaWan-Teck Lim, Quan-Sing Ng, Percy Ivy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2011
Genomic profiles specific to patient ethnicity in lung adenocarcinomaPhilippe Broët, Cyril Dalmasso, Eng Huat Tan, et al.
Cancer|February 3, 2015
Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysisN Gopalakrishna Iyer, Daniel S W Tan, Veronique K M Tan, et al.
Cancer Immunology, Immunotherapy : CII|December 2, 2008
Phenotypic and functional alterations of Vgamma2Vdelta2 T cell subsets in patients with active nasopharyngeal carcinomaKia Joo Puan, John Seng Hooi Low, Terence Wee Kiat Tan, et al.
Head & Neck|June 24, 2014
Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinomaSiok-Hoon Ang, Benjamin Haaland, Sanchalika Acharyya, et al.
Head & Neck|February 6, 2021
Phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinomaMei-Kim Ang, Jose Enrique Montoya, Ekkasit Tharavichitkul, et al.
Clinical Pharmacology in Drug Development|January 19, 2018
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCEng-Huat Tan, Wan-Teck Lim, Myung-Ju Ahn, et al.
International Journal of Cancer|February 1, 2014
Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomicsDaniel S W Tan, Sophie Camilleri-Broët, Eng Huat Tan, et al.
Pageof 11